Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cerus Corporation - Common Stock (NQ:CERS)

1.535 +0.025 (+1.66%)
Streaming Delayed Price Updated: 2:27 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cerus Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
From Cerus Corporation
Via Business Wire
Recap: Cerus Q4 Earnings
Cerus (NASDAQ:CERS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Cerus beat... 
Via Benzinga
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference
From Cerus Corporation
Via Business Wire
Cerus's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q4, Cerus's (NASDAQ:CERS) reported sales totaled $39.87 million. Despite a 26.66% increase in earnings, the company posted a loss of $9... 
Via Benzinga
Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales
Cerus Corp's (NASDAQ: CERS) Q4 FY21 product revenue was $39.9 million, compared to $28.2 million, driven by increased sales of INTERCEPT platelet kits to blood... 
Via Benzinga
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
From Cerus Corporation
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers TCR2 Therapeutics (NASDAQ:TCRR) s... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers DBV Technologies (NASDAQ:DBVT) sh... 
Via Benzinga
Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update
From Cerus Corporation
Via Business Wire
Uncertain Times
The UK inflation rate last month was 5.1%, not a good omen. 
Via Talk Markets
Cerus Corporation to Participate in Stephens Annual Investment Conference
From Cerus Corporation
Via Business Wire
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
From Cerus Corporation
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at... 
Via Benzinga
86 Biggest Movers From Yesterday
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million.... 
Via Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
Via Benzinga
Topics Retirement
Cerus Posts Lower Than Expected Q3 Loss; Raises FY21 Sales Guidance
Cerus Corporation (NASDAQ: CERS) reported Q3 sales of $42.1 million, +44% Y/Y, beating the consensus of $37.27 million. Product revenue reached $36.13 million, +53%,... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to... 
Via Benzinga
Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript
CERS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Cerus Corporation Announces Record Third Quarter 2021 Financial Results and Raises Full-Year Product Revenue Guidance
From Cerus Corporation
Via Business Wire
Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
From Cerus Corporation
Via Business Wire
Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply
From Cerus Corporation
Via Business Wire
Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021
From Cerus Corporation
Via Business Wire
Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference
From Cerus Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.